Drug Search Results
More Filters [+]

BBH-1001

Alternative Names: bbh-1001, bbh1001, bbh 1001
Latest Update: 2016-06-27
Latest Update Note: Clinical Trial Update

Product Description

For Mild Cognitive Impairment; Treatment with supplement consisting of turmeric, fish oil, vitamin D and green tea extract OR placebo. (Sourced from: https://clinicaltrials.gov/ct2/show/NCT02741804)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Cedars-Sinai Medical Center
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for BBH-1001

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title